A Registry Study of Biomarkers in Heart Valve Disease
Beijing Institute of Heart, Lung and Blood Vessel Diseases
200,000 participants
Jan 1, 2016
OBSERVATIONAL
Conditions
Summary
Valvular Heart Disease, impacting 2.5% of the population, is predominantly observed in the elderly and is on the rise. The primary conditions within this category are Aortic Stenosis and Mitral Regurgitation. These conditions are linked to considerable morbidity and mortality, presenting a formidable challenge in optimizing treatment strategies. Pathophysiology of Valvular Heart Disease remains poorly known. The aim of the present study is to identify biomarkers involved in this disease using multi-omics approaches
Eligibility
Inclusion Criteria1
- Patients clinically diagnosed with heart valve disease in Beijing Anzhen Hospital
Exclusion Criteria3
- Age < 18 years
- Failure to obtain medical records and ultrasound data
- Refuse follow-up
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06223906